Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism
2014
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Prevalence of Dietary Supplement Use by Athletes: Systematic Review and Meta-Analysis
2015 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
e-Tourism beyond COVID-19: a call for transformative research
2020
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Organization and dynamics of the actin cytoskeleton during dendritic spine morphological remodeling
2016
Human induced pluripotent stem cells and their use in drug discovery for toxicity testing
2013
Markers of fibrosis, inflammation, and remodeling pathways in heart failure
2014
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Natriuretic peptides and troponins in pulmonary embolism: a meta-analysis
2009
Acute Coronary Syndrome
2010
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Elevated Heart-Type Fatty Acid-Binding Protein Levels on Admission Predict an Adverse Outcome in Normotensive Patients With Acute Pulmonary Embolism
2010
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism
2010
Antithrombotic Therapy for VTE Disease
2016 Standout
GDF-15 for Prognostication of Cardiovascular and Cancer Morbidity and Mortality in Men
2013
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Epidemiology of sarcopenia and insight into possible therapeutic targets
2017
Antithrombotic Therapy for VTE Disease
2012 Standout
Two to Tango: Regulation of Mammalian Iron Metabolism
2010 Standout
Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate
2004
Cardiorenal Syndrome
2008 Standout
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
2013 Standout
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
The structure and functions of the presenilins
2005
Sarcopenia
2019 Standout
Fluorescence nanoscopy in cell biology
2017 StandoutNobel
Glutamate synthase: structural, mechanistic and regulatory properties, and role in the amino acid metabolism
2005 StandoutNobel
Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people
2015
Highlights of the Year in JACC 2007
2008
Exercise-induced skeletal muscle signaling pathways and human athletic performance
2016
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice
2011
Atherosclerosis
2019 Standout
Improving long-term risk prediction in patients with acute chest pain: The Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers
2010
A systematic review and meta-analysis on the prevalence of dietary supplement use by military personnel
2014
β-Alanine as a small molecule neurotransmitter
2010
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
2013
Biomarkers in Heart Failure
2008 Standout
Muscles, exercise and obesity: skeletal muscle as a secretory organ
2012 Standout
Neutrophil recruitment and function in health and inflammation
2013 Standout
Tourism and COVID-19: Impacts and implications for advancing and resetting industry and research
2020 Standout
Brain-Type Natriuretic Peptide Levels in the Prediction of Adverse Outcome in Patients with Pulmonary Embolism
2008
Physiology and Pathophysiology of Carnosine
2013 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction
2013
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
2013
Biomarkers in Relation to the Effects of Ticagrelor in Comparison With Clopidogrel in Non–ST-Elevation Acute Coronary Syndrome Patients Managed With or Without In-Hospital Revascularization
2013
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary
2014
Clinical and Genetic Correlates of Growth Differentiation Factor 15 in the Community
2012
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Diabetic Cardiomyopathy
2018 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study
2011
Biological functions of asparagine synthetase in plants
2010 StandoutNobel
Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults
2011
Incremental Prognostic Value of Biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) Score and High-Sensitivity Cardiac Troponin T in Non-ST-Elevation Acute Coronary Syndrome
2013
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
2016
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Follistatin-Like 1 Is an Akt-Regulated Cardioprotective Factor That Is Secreted by the Heart
2008
A review of theory and practice in scientometrics
2015 Standout
The Use of Drugs and Nutritional Supplements in Top-Level Track and Field Athletes
2009
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin
2009
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2011
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Biomarkers of Cardiovascular Stress and Incident Chronic Kidney Disease
2013
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
2012
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation
2012
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of Timo Peter being referenced
First-line catheter ablation of paroxysmal atrial fibrillation: outcome of radiofrequency vs. cryoballoon pulmonary vein isolation
2015
Effect of Antioxidant Supplementation on Exercise-Induced Cardiac Troponin Release in Cyclists: A Randomized Trial
2013
Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis
2012
Growth Differentiation Factor-15 for Prognostic Assessment of Patients with Acute Pulmonary Embolism
2008
Nutritional strategies to optimize training and racing in middle-distance athletes
2007
Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure
2007
Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction
2007
Prognostic Value of Growth-Differentiation Factor-15 in Patients With Non–ST-Elevation Acute Coronary Syndrome
2007
Innovative approaches in the embryonic stem cell test (EST)
2011
Growth-Differentiation Factor-15 for Long-Term Risk Prediction in Patients Stabilized After an Episode of Non–ST-Segment–Elevation Acute Coronary Syndrome
2009
Circulating Concentrations of Growth-Differentiation Factor 15 in Apparently Healthy Elderly Individuals and Patients with Chronic Heart Failure as Assessed by a New Immunoradiometric Sandwich Assay
2006
Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non–ST-Elevation Acute Coronary Syndrome
2007